ZyVersa Therapeutics, Inc. (ZVSA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -799.12M | -413.69M | -1.41B | -1.52B | -1.77B | -1.22M | -644.4K | -1.91M | -3.78M | -2.79M | -936.39K | -407.62K |
| Operating CF Margin % | - | - | - | - | - | -4695.94% | - | - | - | -17867.64% | - | - |
| Operating CF Growth % | 54.9% | -33681.34% | -218228.65% | -79401.38% | -46821.91% | 56.07% | 31.18% | -369.58% | 17.71% | -569.54% | -140.8% | -29.19% |
| Net Income | -1.79B | 1.58B | -19.81B | -2.21B | -2.26M | -1.42M | -2.4M | -2.76M | -2.83M | -13.34M | -2.9M | -78.51M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | -13.04K | 6.93M | 2.6K | 10.44K | 2.6K | 2.6K | 2.6K |
| Stock-Based Compensation | 55.87M | 17.35M | 73.99M | 59.2M | 72.29M | 160.66K | 257.44M | 160.66K | 223.57K | 296.71K | 243.04K | 365.74K |
| Deferred Taxes | 0 | 0 | -851.66M | 0 | 0 | -2.96K | 9.71M | 9.71K | 0 | -596.07K | -485 | -7.84M |
| Other Non-Cash Items | 937.81M | -2.01B | 19.18B | 630.39M | -1.84B | 130.61K | -273.92M | 0 | 79.2K | 12.25M | 22.82K | 82.96M |
| Working Capital Changes | 582.22K | 190.29K | 498.81K | 0 | 330.99K | -78.18K | 1.59M | 676.68K | -1.26M | -1.4M | 1.7M | 2.61M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 111.89K | 318.26K | 314.8K | -135.24M | 191.44K | 74.39K | 791.25K | 188.76K | -303.84K | -465.95K | 753.5K | 1.76M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1B | -12.51M | 1.86B | -17.72M | 1.85B | 2.63M | 647.84K | 0 | 2.67M | 4.35M | 2.29M | -641.76K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1M | -12.51K | 2.05M | 0 | 1.85M | 2.63M | 647.84K | 0 | 2.67M | 5M | 2.29M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -230K | -10.47M |
| Other Financing | 999M | -12.5M | 1.86B | -17.72M | 1.85B | 0 | 0 | 0 | 0 | -653.33K | 0 | -641.76K |
| Net Change in Cash | 200.88M | -426.2M | 455.89M | -1.54B | 80.61M | 1.41M | 3.44K | -1.91M | -1.1M | 1.56M | 1.35M | -1.05M |
| Free Cash Flow | -799.12M | -413.69M | -1.41B | -1.52B | -1.77B | -1.22M | -3.08B | -1.91M | -3.78M | -2.79M | -936.39K | -407.62K |
| FCF Margin % | - | - | - | - | - | -4695.94% | - | - | - | -17867.64% | - | - |
| FCF Growth % | 54.9% | -33681.34% | 54.3% | -79401.38% | -46821.91% | 56.07% | -328671.51% | -369.58% | 17.71% | -569.54% | -140.8% | -29.19% |
| FCF per Share | -0.10 | -0.07 | -18.18 | -31.61 | -570.36 | -1.13 | -3114.80 | -2.29 | -6.06 | -6.88 | -10.58 | -7.99 |
| FCF Conversion (FCF/Net Income) | 0.45x | 609.65x | 71.04x | 688.15x | 785.16x | 0.86x | 0.27x | 0.69x | 1.34x | 0.21x | 0.32x | 0.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |